We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance on defining intended purpose for Software as a Medical Device (SaMD), to help SaMD manufacturers in meeting their statutory obligations.
Information for patients, healthcare professionals and developers of new medicines
A guide to farming risks, potential problems with public safety and how to avoid accidents
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
How investigators and sponsors should manage clinical trials during COVID-19
How councils should deal with litter, refuse and dog mess, and the penalties they can give.
Principles to support decision making for those involved in safely planning and protecting visiting during outbreaks of infectious illness in adult social care.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Using retractable or foldable aerodynamic rear devices on heavy goods vehicles.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Find out which form to use in different circumstances.
Guidance on the choice of recommended coordinate reference system (CRS) in the UK Geospatial Data Standards Register for exchanging geospatial information
Answers to frequently asked questions on Approved Document O, which sets standards for reducing overheating risk in new residential buildings.
Advice and guidance on the health needs of migrant patients for healthcare practitioners
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).